Data as of May 20
| +0.16 / +1.14%|
The 6 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 16.00, with a high estimate of 20.00 and a low estimate of 15.00. The median estimate represents a +12.68% increase from the last price of 14.20.
The current consensus among 8 polled investment analysts is to Hold stock in PharMerica Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.